{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:40:24Z","timestamp":1761172824822,"version":"build-2065373602"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Extramedullary Plasmacytoma (EMP) is a rare plasma cell neoplasm that originates outside the bone marrow. Primary Extramedullary Plasmacytoma with Diffuse Lymph Node Involvement (PLNEMP) is exceptionally rare. Here, we report a unique case of PLNEMP and significant bone destruction, characterized by a novel\n                    <jats:italic>IGH::NFKB1<\/jats:italic>\n                    fusion gene. A 60-year-old Chinese male presented with palpable enlarged lymph nodes in the left inguinal region. After completing laboratory tests and examinations, it was suggested that there was monoclonal immunoglobulinemia and multiple bone destruction. Pathological examination of the left inguinal lymph node biopsy showed plasmacytoma with monoclonal gammopathy. Genomic profiling identified a novel\n                    <jats:italic>IGH::NFKB1<\/jats:italic>\n                    fusion gene. The two 3\u2032 regulatory region (3\u2032RR) enhancers of the\n                    <jats:italic>IGH<\/jats:italic>\n                    locus were fused to a region 379 bp upstream of\n                    <jats:italic>NFKB1<\/jats:italic>\n                    exon 1, resulting in overexpression of\n                    <jats:italic>NFKB1<\/jats:italic>\n                    . The patient received four cycles of chemotherapy with Mitoxantrone hydrochloride liposome (Lipo-MIT) combined with Bortezomib, Pomalidomide, and Dexamethasone (MVPD), achieving very good partial remission (VGPR) in hematological and partial remission (PR) in extramedullary disease. Subsequently, he underwent autologous stem cell transplantation (ASCT) followed by BCMA CAR-T cell therapy. At 8 months post-transplantation, complete remission (CR) was achieved in hematological parameters, and the extramedullary disease showed a response greater than PR. The patient has survived for 26 months so far. This case highlights the importance of recognizing the rare presentation of PEMP with diffuse lymph node involvement and significant bone destruction. The presence of the novel\n                    <jats:italic>IGH::NFKB1<\/jats:italic>\n                    fusion gene provides insights into the potential role of the NF-\u03baB pathway in the pathogenesis of this disease. The successful treatment with MVPD chemotherapy, ASCT, and BCMA CAR-T therapy demonstrates the potential efficacy of this combined therapeutic approach in achieving long-term remission and survival in such rare cases. Further studies are warranted to explore the therapeutic implications of targeting the NF-\u03baB pathway in similar cases of EMP with bone destruction.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2025.1664103","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:32:39Z","timestamp":1761111159000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Molecular and immunological insights into primary extramedullary plasmacytoma: discovery of a novel IGH::NFKB1 fusion and its impact on disease progression and treatment"],"prefix":"10.3389","volume":"16","author":[{"given":"Ziting","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongbing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenfeng","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jintao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanjie","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingping","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huafei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunlin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3444","article-title":"Trends in solitary plasmacytoma, extramedullary plasmacytoma, and plasma cell myeloma incidence and myeloma mortality by racial-ethnic group, United States 2003-2016","volume":"10","author":"Ellington","year":"2021","journal-title":"Cancer Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2174\/1573405619666230213114231","article-title":"CT and MRI findings of solitary extramedullary plasmacytoma: A series of ten case reports and review of literature","volume":"19","author":"Ding","year":"2023","journal-title":"Curr Med Imaging"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2010.01504.x","article-title":"Extensive soft-tissue involvement by plasmablastic myeloma arising from displaced humeral fractures","volume":"85","author":"De Larrea","year":"2010","journal-title":"Eur J Haematol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830430316","article-title":"Primary plasmacytoma of generalized lymph nodes: a long survivor","volume":"43","author":"Matsushima","year":"1993","journal-title":"Am J Hematol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13256-019-2087-7","article-title":"Primary extramedullary plasmacytoma with diffuse lymph node involvement: a case report and review of the literature","volume":"13","author":"Naymagon","year":"2019","journal-title":"J Med Case Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2005.20.2.183","article-title":"A case of primary plasmacytoma of lymph nodes","volume":"20","author":"Lim","year":"2005","journal-title":"Korean J Intern Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13256-017-1266-7","article-title":"Unusual course of generalized lymph node primary plasmacytoma in a patient with Sj\u00f6gren\u2019s syndrome: a case report","volume":"11","author":"Gorodetskiy","year":"2017","journal-title":"J Med Case Rep"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.hemonc.2015.06.007","article-title":"Primary plasmacytoma involving mediastinal lymph nodes: A diagnostic mimicry of primary mediastinal lymphoma","volume":"9","author":"Salem","year":"2016","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1309\/L2GR-PCFM-G4A3-GHDW","article-title":"Primary lymph node plasmacytomas (plasmacytic lymphomas)","volume":"115","author":"Menke","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2008.03.018","article-title":"Functions of RANKL\/RANK\/OPG in bone modeling and remodeling","volume":"473","author":"Boyce","year":"2008","journal-title":"Arch Biochem Biophys"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403331","article-title":"Bone marrow endothelial cells increase the invasiveness of human multiple myeloma cells through upregulation of MMP-9: evidence for a role of hepatocyte growth factor","volume":"18","author":"Vande Broek","year":"2004","journal-title":"Leukemia"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-09-243535","article-title":"Classical and\/or alternative NF-kappaB pathway activation in multiple myeloma","volume":"115","author":"Demchenko","year":"2010","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27376","article-title":"Plasmablastic lymphoma: 2024 update on diagnosis, risk stratification, and management","volume":"99","author":"Ramirez-Gamero","year":"2024","journal-title":"Am J Hematol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-023-02134-1","article-title":"Non-IG::MYC in diffuse large B-cell lymphoma confers variable genomic configurations and MYC transactivation potential","volume":"38","author":"Zhang","year":"2024","journal-title":"Leukemia"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2632010x221129242","DOI":"10.1177\/2632010X221129242","article-title":"IGH\/BCL2 status better predicts clinico-pathological behavior in primary splenic follicular lymphoma than histological grade and other molecular markers","volume":"15","author":"Verghese","year":"2022","journal-title":"Clin Pathol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2024.1362081","article-title":"Comprehensive detection of CRLF2 alterations in acute lymphoblastic leukemia: a rapid and accurate novel approach","volume":"11","author":"Gil","year":"2024","journal-title":"Front Mol Biosci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1038\/s41467-017-00638-w","article-title":"Expressed fusion gene landscape and its impact in multiple myeloma","volume":"8","author":"Cleynen","year":"2017","journal-title":"Nat Commun"},{"key":"B19","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1182\/blood.V124.21.721.721","article-title":"Frequent Igh fusion transcripts with clinical impact in multiple myeloma","volume":"124","author":"Cleynen","year":"2014","journal-title":"Blood"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1664103\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:32:43Z","timestamp":1761111163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1664103\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":19,"alternative-id":["10.3389\/fimmu.2025.1664103"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1664103","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"article-number":"1664103"}}